Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Dhami, S; Nurmatov, U; Roberts, G; Pfaar, O; Muraro, A; Ansotegui, IJ; Calderon, M; Cingi, C; Demoly, P; Durham, S; van Wijk, RG; Halken, S; Hamelmann, E; Hellings, P; Jacobsen, L; Knol, E; Larenas-Linnemann, D; Lin, S; Maggina, V; Oude-Elberink, H; Pajno, G; Panwankar, R; Pastorello, E; Pitsios, C; Rotiroti, G; Timmermans, F; Tsilochristou, O; Varga, EM; Wilkinson, J; Williams, A; Worm, M; Zhang, L; Sheikh, A.
Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.
Clin Transl Allergy. 2016; 6(7):12-12 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
Varga Eva-Maria

Dimensions Citations:

Plum Analytics:
Number of Figures: 1
The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis. We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

Find related publications in this database (Keywords)
Allergic rhinoconjunctivitis
Allergen immunotherapy
© Meduni Graz Impressum